Oncternal Therapeutics, Inc.
USD0.53
-0.17 (-24.12%)
CEO
James B. Breitmeyer
IPO Date
2004-02-03
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.70
Prev. Close
$0.69
Day Low
$0.53
Day High
$0.70
52W Low
$0.53
52W High
$10.61
Market Cap
$0.00B
Volume
0.64M
| 2,200 |
| $8.10 |
| 24 Jun 2024 | CARTER MICHAEL G | director | A-Award | Acquired | 2,200 | $8.10 |
| 24 Jun 2024 | THEUER CHARLES | director | A-Award | Acquired | 2,200 | $8.10 |
| 24 Jun 2024 | HALE DAVID F | director | A-Award | Acquired | 3,300 | $8.10 |
| 24 Jun 2024 | MAZANET ROSEMARY | director | A-Award | Acquired | 2,200 | $8.10 |
| 24 Jun 2024 | Wills Robert James | director | A-Award | Acquired | 2,200 | $8.10 |
| 10 Apr 2024 | Wills Robert James | director | P-Purchase | Acquired | 3,086 | $8.96 |
| 1 Apr 2024 | Wills Robert James | director | P-Purchase | Acquired | 6,914 | $8.48 |
| 27 Feb 2024 | HALE DAVID F | director | P-Purchase | Acquired | 266 | $9.04 |